abemaciclib
eli lilly
['breast', 'abema', 'bcsm', 'abemaciclib']
a clinically meaningful absolute risk reduction in idfs &amp; drfs w/ abemaciclib + endocrine therapy was maintained in hr+/her2 , high-risk early breast cancer regardless of age. #asco23 #asco2023 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.